Atomo Diagnostics Ltd. (AU:AT1) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Atomo Diagnostics Limited has announced the cessation of 4 million options due to unmet conditions, with the lapse occurring on April 30, 2024. The terminated options were set to expire on the same day, with exercise prices at $0.60 and $0.40 respectively.
For further insights into AU:AT1 stock, check out TipRanks’ Stock Analysis page.